Forecasting The Future: 13 Analyst Projections For GoodRx Holdings
Portfolio Pulse from Benzinga Insights
In the latest quarter, 13 analysts provided ratings for GoodRx Holdings (NASDAQ:GDRX), showing a mix of bullish and bearish perspectives. The average 12-month price target is $9.46, with a high of $16.00 and a low of $7.50. Recent analyst actions include several rating upgrades and price target increases.
May 16, 2024 | 4:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
GoodRx Holdings (NASDAQ:GDRX) received mixed ratings from 13 analysts, with an average 12-month price target of $9.46. Recent upgrades and price target increases suggest a positive short-term outlook.
The majority of analysts have a somewhat bullish or indifferent stance on GDRX, with several recent upgrades and price target increases. This suggests a positive short-term outlook for the stock.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100